Passage Bio, Inc.

PASG · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$65-$102-$136-$185
Dep. & Amort.$3$4$4$2
Deferred Tax$0$0$0$3
Stock-Based Comp.$6$11$0$33
Change in WC$4$5-$8$11
Other Non-Cash$4$4$23$10
Operating Cash Flow-$48-$78-$118-$127
Investing Activities
PP&E Inv.-$0-$0-$5-$26
Net Acquisitions$0$0$0$8
Inv. Purchases-$88-$129-$158-$203
Inv. Sales/Matur.$143$195$188$182
Other Inv. Act.$0$0$0-$8
Investing Cash Flow$55$65$25-$46
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$9$0$0$167
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0-$2-$0
Financing Cash Flow$9$0-$1$167
Forex Effect$0$0$0$0
Net Chg. in Cash$16-$13-$94-$6
Supplemental Information
Beg. Cash$22$35$129$135
End Cash$38$22$35$129
Free Cash Flow-$48-$78-$123-$153